Anastasios Gianakakos has an estimated net worth of $16.6 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., LianBio, and MyoKardia Inc.
2018 was Anastasios Gianakakos's most active year for acquiring shares with 21 total transactions. Anastasios Gianakakos's most active month to acquire stocks was the month of December. 2008 was Anastasios Gianakakos's most active year for disposing of shares, totalling 178 transactions. Anastasios Gianakakos's most active month to dispose stocks was the month of April. 2009 saw Anastasios Gianakakos paying a total of $1,080,117.20 for 158,000 shares, this is the most they've acquired in one year. In 2020 Anastasios Gianakakos cashed out on 1,357,454 shares for a total of $7,588,376.85, their largest year based on trade value.